+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Altimmune - logo

Altimmune is an immunotherapeutic biotechnology company that develops immunotherapeutic products and vaccines to address public health and biodefense needs. It offers NasoVAX, HepTcell, NasoShield and Oncosyn. The company also develops products for use in companion and commercial livestock and offers immunotherapeutic products for various disease indications. The company was founded in 1997 and is based in Gaithersburg, Maryland with operating sites in the UK and France.

Influenza A virus H5N1 subtype - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza A virus H5N1 subtype - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Pandemic Influenza - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Pandemic Influenza - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 121 Pages
  • Global
From
Altimmune Inc (ALT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Altimmune Inc (ALT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • December 2023
  • 89 Pages
From
Comprehensive Report on Altimmune Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Altimmune Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator